Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

GLP-1R–Targeting Magnetic Nanoparticles for Pancreatic Islet Imaging

Journal Article · · Diabetes
DOI:https://doi.org/10.2337/db13-1543· OSTI ID:1628017
 [1];  [2];  [3];  [4];  [2];  [2];  [3];  [2]
  1. Harvard Medical School, Boston, MA (United States). Dept. of Radiology. Athinoula A. Martinos Center for Biomedical Imaging. Molecular Imaging Lab.; DOE/OSTI
  2. Harvard Medical School, Boston, MA (United States). Dept. of Radiology. Athinoula A. Martinos Center for Biomedical Imaging. Molecular Imaging Lab.
  3. Harvard Medical School, Boston, MA (United States). Massachusetts General Hospital. Dept. of Radiology. Athinoula A. Martinos Center for Biomedical Imaging
  4. Harvard Medical School, Boston, MA (United States). Dept. of Radiology. Athinoula A. Martinos Center for Biomedical Imaging. Molecular Imaging Lab.; China Pharmaceutical Univ., Nanjing (China). School of Pharmacy. Center for Drug Discovery
Noninvasive assessment of pancreatic b-cell mass would tremendously aid in managing type 1 diabetes (T1D). Toward this goal, we synthesized an exendin-4 conjugated magnetic iron oxide–based nanoparticle probe targeting glucagon-like peptide 1 receptor (GLP1R), which is highly expressed on the surface of pancreatic b-cells. In vitro studies in βTC-6, the b-cell line, showed specific accumulation of the targeted probe (termed MN-Ex10-Cy5.5) compared with nontargeted (termed MN-Cy5.5). In vivo magnetic resonance imaging showed a significant transverse relaxation time (T2) shortening in the pancreata of mice injected with the MN-Ex10-Cy5.5 probe compared with control animals injected with the nontargeted probe at 7.5 and 24 h after injection. Furthermore, ΔT2 of the pancreata of prediabetic NOD mice was significantly higher than that of diabetic NOD mice after the injection of MN-Ex10-Cy5.5, indicating the decrease of probe accumulation in these animals due to β-cell loss. Of note, ΔT2 of prediabetic and diabetic NOD mice injected with MN-Cy5.5 was not significantly changed, reflecting the nonspecific mode of accumulation of nontargeted probe. We believe our results point to the potential for using this agent for monitoring the disease development and response of T1D to therapy.
Research Organization:
Massachusetts General Hospital, Boston, MA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
SC0008430
OSTI ID:
1628017
Journal Information:
Diabetes, Journal Name: Diabetes Journal Issue: 5 Vol. 63; ISSN 0012-1797
Publisher:
American Diabetes AssociationCopyright Statement
Country of Publication:
United States
Language:
English

References (68)

PET imaging ofβ-cell mass: is it feasible? journal October 2012
The incretin hormones: from scientific discovery to practical therapeutics journal May 2012
18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster? journal December 2011
Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma journal December 2012
GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging journal November 2009
Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages journal January 2011
A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice journal February 2009
The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics journal May 2010
Synthesis and evaluation of [18F]exendin (9–39) as a potential biomarker to measure pancreatic β-cell mass journal February 2012
Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor journal October 2013
Molecular Imaging with Theranostic Nanoparticles journal September 2011
In Vivo Imaging of Transplanted Islets with 64 Cu-DO3A-VS-Cys 40 -Exendin-4 by Targeting GLP-1 Receptor journal August 2011
Endocytosis and Intracellular Trafficking as Gateways for Nanomedicine Delivery: Opportunities and Challenges journal August 2012
β-Cell death during progression to diabetes journal December 2001
In vivo multimodal imaging of transplanted pancreatic islets journal June 2006
Erratum: Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis journal November 2016
Endocytosis at the nanoscale journal January 2012
Imaging inflammation of the pancreatic islets in type 1 diabetes journal August 2004
Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent journal March 2006
Multifunctional Magnetic Nanocarriers for Image-Tagged SiRNA Delivery to Intact Pancreatic Islets journal November 2008
In Vivo Imaging of Autologous Islet Grafts in the Liver and Under the Kidney Capsule in Non-Human Primates journal June 2009
Variable Nanoparticle-Cell Adhesion Strength Regulates Cellular Uptake journal September 2010
Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model journal February 2000
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe journal March 2004
Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug journal September 2010
Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes journal August 2005
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients journal January 2011
For Insulinomas, No Place to Hide journal November 2009
Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas journal June 2008
Multifunctional nanocarrier for image-guided delivery of bioactive agents journal October 2007
In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets journal September 2006
Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation journal January 2011
Manganese-Enhanced Magnetic Resonance Imaging Detects Declining Pancreatic β-Cell Mass in a Cyclophosphamide-Accelerated Mouse Model of Type 1 Diabetes journal December 2012
The Magnetic Appeal of Silencing Theranostics journal November 2012
Identification and Characterization of GLP-1 Receptor–Expressing Cells Using a New Transgenic Mouse Model journal March 2014
Normalization of Insulin Responses to Glucose by Overnight Infusion of Glucagon-Like Peptide 1 (7–36) Amide in Patients With NIDDM journal November 1996
Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT journal July 2010
Development and Evaluation of 18F-TTCO-Cys40-Exendin-4: A PET Probe for Imaging Transplanted Islets journal January 2013
In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with 68Ga-Labeled DO3A-Exendin-4 journal June 2013
Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma journal January 2012
Imaging of pancreatic islet cells journal November 2011
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients journal August 1993
Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis journal February 2012
18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma journal December 2011
Translational Molecular Imaging of Diabetes journal June 2013
Crosslinked Iron Oxides (CLIO) journal February 2002
The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI journal July 2013
Near-Infrared Fluorescent Probe for Imaging of Pancreatic β Cells journal July 2010
Mono-PEGylated Dimeric Exendin-4 as High Receptor Binding and Long-Acting Conjugates for Type 2 Anti-Diabetes Therapeutics journal March 2011
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging journal February 2012
In vivo imaging of islet transplantation journal December 2005
In vivo imaging of siRNA delivery and silencing in tumors journal February 2007
Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis journal May 2012
GLP-1–Receptor Scanning for Imaging of Human Beta Cells Transplanted in Muscle journal September 2010
Noninvasive MRI of β-cell function using a Zn 2+ -responsive contrast agent journal October 2011
Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog journal July 2011
Multifunctional Magnetic Nanocarriers for Image-Tagged SiRNA Delivery to Intact Pancreatic Islets journal November 2008
In Vivo Imaging of Autologous Islet Grafts in the Liver and Under the Kidney Capsule in Non-Human Primates journal June 2009
Variable Nanoparticle-Cell Adhesion Strength Regulates Cellular Uptake journal September 2010
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe journal March 2004
Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug journal September 2010
Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways journal May 2008
Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes journal August 2005
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients journal January 2011
Glucagon-Like Peptide-1 Receptor Imaging for Localization of Insulinomas journal November 2009
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia journal June 2007
A Theranostic Small Interfering RNA Nanoprobe Protects Pancreatic Islet Grafts From Adoptively Transferred Immune Rejection journal November 2012
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation journal April 2011

Cited By (11)

Exendin-4 analogs in insulinoma theranostics
  • Jansen, Tom. J. P.; van Lith, Sanne. A. M.; Boss, Marti
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 62, Issue 10 https://doi.org/10.1002/jlcr.3750
journal August 2019
Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice journal November 2014
Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models journal May 2018
Combined Optical Coherence and Fluorescence Microscopy to assess dynamics and specificity of pancreatic beta-cell tracers journal May 2015
Liraglutide, a human glucagon‐like peptide‐1 analogue, stimulates AKT‐dependent survival signalling and inhibits pancreatic β‐cell apoptosis journal March 2018
Characterization of 5-(2-18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas journal January 2016
Pancreatic imaging: Current status of clinical practices and small animal studies journal September 2017
Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cells journal February 2017
Targets and probes for non-invasive imaging of β-cells journal December 2016
Pancreatic β-cell imaging in humans: fiction or option? journal October 2015
Characterization of 5-(2-18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas journal January 2016

Similar Records

GLP-1 receptor antagonist as a potential probe for pancreatic {beta}-cell imaging
Journal Article · Thu Nov 19 23:00:00 EST 2009 · Biochemical and Biophysical Research Communications · OSTI ID:22199885

Substance P preserves pancreatic β-cells in type 1 and type 2 diabetic mice
Journal Article · Tue May 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23137158

Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model
Journal Article · Fri Sep 03 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22202760